3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione has been researched along with Neurofibromatosis 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adusumilli, PS; Bialik, A; Bodd, FM; Chang, JC; Chen, YB; Ladanyi, M; Li, Y; Lopardo, J; Offin, MD; Rusch, VW; Sauter, JL; Travis, WD; Yang, SR; Zauderer, MG | 1 |
1 other study(ies) available for 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Neurofibromatosis 2
Article | Year |
---|---|
Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma.
Topics: Adaptor Proteins, Signal Transducing; Humans; Immunohistochemistry; Mesothelioma; Mesothelioma, Malignant; Neurofibromatosis 2; Neurofibromin 2; Transcription Factors; YAP-Signaling Proteins | 2023 |